Clinical trial
Prospective Multicenter Study of Genetic Factors Predictive of the Pharmacodynamics of Trastuzumab in Patients With Metastatic Breast Cancer
NCT00896376 is registered in ClinicalTrials.gov with Centre Antoine Lacassagne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Multicenter Study of Genetic Factors Predictive of the Pharmacodynamics of Trastuzumab in Patients With Metastatic Breast Cancer
- Lead sponsor
- Centre Antoine Lacassagne
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- September 30, 2010
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer